trending Market Intelligence /marketintelligence/en/news-insights/trending/oOzqm8-0RN8GDwagOBiFaA2 content esgSubNav
In This List

Concert Pharmaceuticals director resigns

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Concert Pharmaceuticals director resigns

Concert Pharmaceuticals Inc. said Meghan FitzGerald resigned from the board, effective Dec. 11, due to other work commitments.

FitzGerald works in private equity and resigned her seat because one of her new portfolio companies invests in the biotechnology industry.

Lexington, Mass.-based Concert Pharmaceuticals operates as a clinical-stage biopharmaceutical company.